|
Sex
|
M
|
M
|
F
|
F
|
F
|
|
Age
|
68
|
66
|
61
|
47
|
73
|
|
Activity investigated cycle [MBq]
|
7654
|
7425
|
7420
|
7409
|
7410
|
|
Diagnosis
|
NET small intestine
|
NET
|
NET terminal ileum
|
NET pancreas
|
NET stomach
|
|
Metastases (PET/CT)
|
|
- Extend
|
Medium
|
Medium
|
Medium
|
Medium
|
Medium
|
|
- Type (VIS = visceral, LYM = lymph, OSS = osseous)
|
Mainly VIS (liver), LYM
|
Mainly LYM, VIS (liver)
|
Mainly VIS (liver), LYM, OSS
|
Mainly LYM, VIS (liver and other)
|
Mainly VIS (liver), OSS
|
|
Proliferation index
|
Ki67 3–4%
|
Ki67 5–10%
|
Ki67 1%
|
Ki67 10%
|
Ki67 10%
|
|
Pre-therapies
|
SSA-analogues
|
Interferon alpha
|
Hemicolectomy, SSA-analogues, radioembolization
|
Chemotherapy (stroptozotocin/5-FU, dacarbazapin, capecitabin/Te-modal)
|
SSA-analogues, bisphosphonate therapy
|
|
Blood pre-therapy
|
|
- Leukocytes [G/l]
|
7.76
|
10.4
|
3.79
|
3.93
|
10.2
|
|
- Erythrocytes [T/l]
|
4.58
|
4.50
|
4.43
|
3.73
|
4.42
|
|
- Thrombocytes [G/l]
|
207
|
294
|
297
|
177
|
303
|
|
- Haematocrit
|
0.421
|
0.442
|
0.373
|
0.341
|
0.399
|
